Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nanogen, Inc. (NGEN) -- Ignore unavailable to you. Want to Upgrade?

To: BradleyMarshall who wrote (97)	1/25/2000 1:16:00 PM
From: tuck	Read Replies (1) \| Respond to of 258

Bradley, I've just seen it mentioned along with other applications in PRs, but no details on their program in the area, if any. It just seems that one could hook up a bunch of these chips and do screening in the same way as parallel processing in computers. The total cost might well be substantially less than systems of equal capability. To my knowledge, the benchmark in screening is 100,000 assays in twelve hours, held by ABSC's UHTSS. It ain't cheap. There is no doubt this is a more complex and ambitious application, and it may not be feasible. It would make sense to have the chips out in the commercial field for a while before going too far with such expensive projects. The technology could offer a quantum leap over UHTSS, or it could offer little in screening. I just don't understand the details well enough. Cheers, Tuck